RVPH
Reviva Pharmaceuticals Holdings Inc.
NASDAQ: RVPH · HEALTHCARE · BIOTECHNOLOGY
$0.87
+0.43% today
Updated 2026-04-30
Market cap
$11.68M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.48
Dividend yield
—
52W range
$1 – $23
Volume
1.6M
Reviva Pharmaceuticals Holdings Inc. (RVPH) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $65.24M | $2600.00 | $8.76M | $31.40M | $18.92M | $23.70M | $15.50M |
| Cash & equivalents | — | $193.00 | $8.76M | $29.69M | $18.52M | $23.37M | $13.48M |
| Current assets | $65.24M | $193.00 | $8.76M | $31.40M | $18.92M | $23.70M | $14.68M |
| Total liabilities | $6.09M | $6.81M | $3.30M | $2.72M | $10.53M | $17.98M | $14.69M |
| Current liabilities | $6.09M | $100102.00 | $1.33M | $2.34M | $9.96M | $17.18M | $14.60M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | — | $-6.81M | $5.47M | $28.69M | $8.39M | $5.72M | $812572.00 |
| Retained earnings | $-53.68M | $-54.53M | $-58.31M | $-66.83M | $-95.09M | $-134.35M | $-164.27M |
| Accounts receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |